As I understand it, the NGPDT is currently being used in China and South Africa, at least, and there is a facility being built in Cambodia, presumably for medical tourism. It would appear that this therapy works and has several years of successful use behind it. Obviously there have to be rigid, successful, trials in a first world country before the therapy can be marketed in the highly profitable markets in the advanced countries. The ultimate market is always the USA. Successful trials in Australia will lead to approval in the USA. These trials are already underway at Monash University. As I understand the announcements, IVX simply take over the management of these trials and CHO provide the money. I guess that CHO have to have someone to manage the trials and IVX can get a tax benefit which is not available to CHO if they finance them directly. As well this deal gives CHO access to about a $100M of tax losses if the trials are successful and the therapy is rolled out in Australia. In any case they will own more than 70% of IVX. It is easy to see the advantages of the deal for CHO. The best I can see for IVX shareholders, is that it beats liquidation.
- Forums
- ASX - By Stock
- Ann: Strategic Transaction Update
As I understand it, the NGPDT is currently being used in China...
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $38.54M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $10.86K | 1.811M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1740301 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 5934158 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1740301 | 0.005 |
23 | 12918100 | 0.004 |
18 | 9471186 | 0.003 |
6 | 4300490 | 0.002 |
8 | 14900000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 5934158 | 12 |
0.007 | 3744796 | 9 |
0.008 | 4071649 | 7 |
0.009 | 3275299 | 10 |
0.010 | 8578900 | 6 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
0.6¢ |
  |
Change
0.001 ( 9.09 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.6¢ | 0.5¢ | 23889 | ||
Last updated 14.48pm 06/05/2024 ? |
Featured News
IVX (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online